Newsletter
Paroxetine vs Quetiapine and Hypercapnia, SARS-CoV-2 Vaccination and COVID-19 Outcomes, USPSTF Recommendation on Anxiety in Children and Adolescents, and more

JAMA Editor’s Summary

Paroxetine vs Quetiapine and Hypercapnia, SARS-CoV-2 Vaccination and COVID-19 Outcomes, USPSTF Recommendation on Anxiety in Children and Adolescents, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the , issue.
October 11, 2022

Paroxetine vs Quetiapine and Hypercapnia, SARS-CoV-2 Vaccination and COVID-19 Outcomes, USPSTF Recommendation on Anxiety in Children and Adolescents, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the October 11, 2022, issue.

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
Nashville’s Opportunity: Eco-Action or Anxiety In this excerpt from a Climate x Health Twitter Spaces live chat, experts from Vanderbilt, Oak Ridge National Laboratory, and others discuss hope and want listeners to be energetic and reject “doomerism” while embracing reality and emphasizing teamwork without ego to accomplish individual and systemic goals. This conversation was hosted live from the AAMC conference in Nashville.